AMD3465 is the second generation of CXCR4 antagonist that can inhibit the migration of AML cells induced by SDF‐1 and multiple intracellular signalling pathways responsible for cell survival.57 The gene discussed is CXCL12; the disease is acute myeloid leukemia.